NCT02044523View on ClinicalTrials.gov

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
Interventions
DEVICE

Transient elastography, acoustic radiation force impulse, magnetic resonance elastography

Transient elastography (Fibroscan) Acoustic Radiation Force Impulse (ARFI) Magnetic Resonance Elastography (MRE)

Trial Locations (1)

H2X 0A9

Centre Hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT02044523 - Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound | Biotech Hunter | Biotech Hunter